Delivery Order SPE2DB22D1041-SPE2DB25FUBH2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $62,000 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90 count). The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 16 mg tablets (90-count) valued at $7,694.19 under a firm fixed price contract. This non-competitive, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count) with a ceiling value of $1,171.70. This competitive, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,163.90 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a completion date of July 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Candesartan cilexetil is an angiotensin receptor blocker used for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,485.26 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles) under a firm fixed-price contract. This competitively awarded delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a single transaction within DLA's pharmaceutical supply chain operations. The contract involves no set-aside designation and is being performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.69 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) with a firm fixed price structure. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation and represents a competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,529.28 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $59,408.56. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBH2Delivery Order
The Defense Logistics Agency awarded a $40,296.55 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Candesartan Cilexetil 32 mg, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract executed under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This contract represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. Candesartan Cilexetil is an antihypertensive medication commonly used in military and veteran healthcare systems. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its established capability to meet DLA procurement standards through open competition, with delivery orders ranging from nominal amounts to substantial purchases. The award reflects the company's critical role as a pharmaceutical prime vendor, supplying brand-name and generic medications, vaccines, and specialized medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.3k | 8/4/25 |